Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2025-01-03T14:28:07.286Z Has data issue: false hasContentIssue false
  • English
  • Français

The utility and sustainability of US Ebola treatment centers during the coronavirus disease 2019 (COVID-19) pandemic

Part of: SARS-CoV-2/COVID-19

Published online by Cambridge University Press:  22 February 2022

Jocelyn J. Herstein Open the ORCID record for Jocelyn J. Herstein [Opens in a new window] ,
Paul D. Biddinger Open the ORCID record for Paul D. Biddinger [Opens in a new window] ,
Shawn G. Gibbs Open the ORCID record for Shawn G. Gibbs [Opens in a new window] ,
Angela L. Hewlett ,
Aurora B. Le Open the ORCID record for Aurora B. Le [Opens in a new window] ,
Michelle M. Schwedhelm Open the ORCID record for Michelle M. Schwedhelm [Opens in a new window]  and
John J. Lowe
Jocelyn J. Herstein*
Affiliation:
University of Nebraska Medical Center, Omaha, Nebraska
Paul D. Biddinger
Affiliation:
Massachusetts General Hospital, Boston, Massachusetts
Shawn G. Gibbs
Affiliation:
Texas A&M University, College Station, Texas
Angela L. Hewlett
Affiliation:
University of Nebraska Medical Center, Omaha, Nebraska Nebraska Medicine, Omaha, Nebraska
Aurora B. Le
Affiliation:
University of Michigan, Ann Arbor, Michigan
Michelle M. Schwedhelm
Affiliation:
Nebraska Medicine, Omaha, Nebraska
John J. Lowe
Affiliation:
University of Nebraska Medical Center, Omaha, Nebraska
*
Author for correspondence: Jocelyn J. Herstein, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

In response to the 2014–2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We sought to determine the ongoing sustainability of ETCs and to identify how ETC capabilities have affected hospital, local, and regional coronavirus disease 2019 (COVID-19) readiness and response.

Design:

An electronic survey included both qualitative and quantitative questions and was structured into 2 sections: operational sustainability and role in the COVID-19 response.

Setting and participants:

The survey was distributed to site representatives from the 56 originally designated ETCs, and 37 (66%) responded.

Methods:

Data were coded and analyzed using descriptive statistics.

Results:

Of the 37 responding ETCs, 33 (89%) reported that they were still operating, and 4 had decommissioned. ETCs that maintain high-level isolation capabilities incurred a mean of $234,367 in expenses per year. All but 1 ETC reported that existing capabilities (eg, trained staff, infrastructure) before COVID-19 positively affected their hospital, local, and regional COVID-19 readiness and response (eg, ETC trained staff, donated supplies, and shared developed protocols).

Conclusions:

Existing high-level isolation capabilities and expertise developed following the 2014–2016 EVD epidemic were leveraged by ETCs to assist hospital-wide readiness for COVID-19 and to support responses by other local and regional hospitals However, ETCs face continued challenges in sustaining those capabilities for high-consequence infectious diseases.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 44 , Issue 4 , April 2023 , pp. 643 - 650
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Interim guidance for US hospital preparedness for patients under investigation (PUIs) or with confirmed Ebola virus disease (EVD): a framework for a tiered approach. Centers for Disease Control and Prevention website. http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/hospitals.html. Accessed June 20, 2021.Google Scholar
Regional treatment network for Ebola and other special pathogens. US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response website. https://www.phe.gov/Preparedness/planning/hpp/reports/Documents/RETN-Ebola-Report-508.pdf. Published 2017. Accessed July 27, 2021.Google Scholar
Herstein, JJ, Biddinger, PD, Kraft, CS, et al. Initial costs of Ebola treatment centers in the United States. Emerg Infect Dis 2016;22:350–352.Google ScholarPubMed
Herstein, JJ, Biddinger, PD, Gibbs, SG, et al. Sustainability of high-level isolation capabilities among US Ebola treatment centers. Emerg Infect Dis 2017;23:965–967.CrossRefGoogle ScholarPubMed
Herstein, JJ, Le, AB, McNulty, LA, et al. Update on Ebola treatment center costs and sustainability, United States, 2019. Emerg Infect Dis 2020;26:1007–1009.CrossRefGoogle Scholar
Division of National Healthcare Preparedness Programs, Office of Emergency Management. Hospital preparedness program (HPP) Ebola preparedness and response activities. EP-U3R-15-002. US Department of Health and Human Services website. https://www.grants.gov/view-opportunity.html?oppId=274709. Published 2015. Accessed April 8, 2019.Google Scholar
Flinn, JB, Hynes, NA, Sauer, LM, Maragakis, LL, Garibaldi, BT. The role of dedicated biocontainment patient care units in preparing for COVID-19 and other infectious disease outbreaks. Infect Control Hosp Epidemiol 2021;42:208–211.CrossRefGoogle ScholarPubMed
How Cedars-Sinai prepared for pandemic patients. Cedars Sinai website. https://www.cedars-sinai.org/newsroom/how-cedars-sinai-prepared-for-pandemic-patients/. Accessed July 20, 2021.Google Scholar
Johnson, DW and Rafique, MB. A rapidly evolving response to COVID-19. ASA Monitor 2020;84:14–16.Google Scholar
The National Special Pathogens System (NSPS) of care. National Emerging Special Pathogens Training and Education Center (NETEC) website. https://netec.org/nsps/. Accessed July 20, 2021.Google Scholar
Selvaraj, SA, Lee, KE, Harrell, M, Ivanov, I, Allegranzi, B. 2018 infection rates and risk factors for infection among health workers during Ebola and Marburg virus outbreaks: a systematic review. J Infect Dis 218 suppl 5:S679–S689.CrossRefGoogle ScholarPubMed
Health worker Ebola infections in Guinea, Liberia, and Sierra Leone. World Health Organization website. https://www.who.int/csr/resources/publications/ebola/health-worker-infections/en/. Published 2015. Accessed June 20, 2021.Google Scholar
Xiao, J, Fang, M, Chen, Q, He, B. SARS, MERS and COVID-19 among healthcare workers: a narrative review. J Infect Public Health 2020;13:843–848.Google ScholarPubMed
Nguyen, LH, Drew, DA, Graham, MS, et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5:e475–e483.CrossRefGoogle ScholarPubMed
Wilkason, C, Lee, C, Sauer, LM, Nuzzo, J, McClelland, A. Assessing and reducing risk to healthcare workers in outbreaks. Health Secur 2020;18:205–211.Google ScholarPubMed
Herstein, JJ, Le, AB, McNulty, LA, et al. An update on US Ebola treatment center personnel management and training. Am J Infect Control 2020;48:375–379.Google ScholarPubMed
COVID-19 nursing home data. Centers for Medicare and Medicaid Services (CMS) website https://data.cms.gov/covid-19/covid-19-nursing-home-data. Accessed August 1, 2021.Google Scholar
Doll, M, Hewlett, AL, Bearman, G. Infection prevention in the hospital from past to present: evolving roles and shifting priorities. Curr Infect Dis Rep 2016;18(5):16.CrossRefGoogle ScholarPubMed
Popescu, S. A Canary in a COVID Coal Mine: Building Better Health-C are Biopreparedness Policy World Med Health Policy 2020. doi: 10.1002/wmh3.353. Published August 7, 2020. Accessed February 22, 2022.Google Scholar
Cable, J, Heymann, DL, Uzicanin, A, et al. Pandemic diseases preparedness and response in the age of COVID-19-a symposium report. Ann N Y Acad Sci 2021;1489:17–29.Google ScholarPubMed
Supplementary material: PDF

Herstein et al. supplementary material

Herstein et al. supplementary material

Download Herstein et al. supplementary material(PDF)
PDF 143.2 KB